Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 12:52 pm Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Kynam Capital Management, LP | 3,005,904 5.500% | 3,005,904 (New Position) | Filing History |
| 2024-02-14 12:51 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Kynam Capital Management, LP | 5,854,766 6.800% | 5,854,766 (New Position) | Filing History |
| 2024-02-14 12:50 pm Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Kynam Capital Management, LP | 5,660,000 6.670% | 5,660,000 (New Position) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management, LP | 3,650,339 8.220% | 2,241,241 (+159.06%) | Filing History |
| 2024-02-14 12:47 pm Purchase | 2023-12-31 | 13G | MorphoSys AG MOR | Kynam Capital Management, LP | 3,690,331 9.800% | 3,690,331 (New Position) | Filing History |
| 2024-02-14 12:45 pm Unchanged | 2023-12-31 | 13G | Burning Rock Biotech Limited BNR | Kynam Capital Management, LP | 869,443 10.190% | 0 (Unchanged) | Filing History |
| 2024-01-10 4:08 pm Purchase | 2023-12-31 | 13G | Burning Rock Biotech Limited BNR | Kynam Capital Management, LP | 869,443 10.190% | 130,285 (+17.63%) | Filing History |
| 2023-09-06 4:54 pm Purchase | 2023-08-31 | 13G | 2seventy bio, Inc. TSVT | Kynam Capital Management, LP | 5,953,825 11.700% | 5,953,825 (New Position) | Filing History |
| 2023-03-21 5:40 pm Sale | 2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 2,025,234 5.000% | -38,398,598 (-94.99%) | Filing History |
| 2023-02-13 09:25 am Unchanged | 2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management, LP | 4,420,349 9.200% | 0 (Unchanged) | Filing History |
| 2023-02-10 3:51 pm Purchase | 2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management, LP | 4,420,349 9.200% | 4,420,349 (New Position) | Filing History |
| 2023-02-10 1:20 pm Purchase | 2022-12-30 | 13G | Vera Therapeutics, Inc. VERA | Kynam Capital Management, LP | 1,409,098 5.100% | 1,409,098 (New Position) | Filing History |
| 2023-02-10 1:18 pm Purchase | 2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Kynam Capital Management, LP | 40,423,832 5.000% | 40,423,832 (New Position) | Filing History |
| 2023-02-10 1:16 pm Purchase | 2022-12-30 | 13G | Burning Rock Biotech Limited BNR | Kynam Capital Management, LP | 739,158 8.400% | 739,158 (New Position) | Filing History |